EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Colchicine and cardiovascular events: An updated meta‐analysis of published randomized controlled trials

Sining Xie, Federica Galimberti, Elena Olmastroni, Alberico L Catapano, Manuela Casula

Journal of Internal Medicine · 2025-12 · 298 (6) · 711-717

DOI: 10.1111/joim.20107 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Journal of Internal Medicine, online erschienen am 07.07.2025. Verfasst von Sining Xie und 4 weiteren Autor:innen. Beteiligte Einrichtung: Epidemiology and Preventive Pharmacology Service (SEFAP), Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy. Hauptthemen laut MEDLINE: Colchicine, Cardiovascular Diseases. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Colchicine shows promise in reducing cardiovascular risk, but a recent study raised the question whether this is really the case. We conducted a meta‐analysis of randomized controlled trials (RCTs) to assess its impact on cardiovascular outcomes in secondary prevention.

Methods

We systematically searched major databases up to March 2025 for RCTs comparing colchicine to placebo over a treatment duration of ≥12 months, reporting major adverse cardiovascular events (MACEs). Both fixed‐ and random‐effects models were used to compute pooled risk ratios (RRs) and 95% confidence intervals.

Results

Six RCTs comprising 21,774 patients were included. Colchicine significantly reduced the risk of MACEs (RR 0.74 [0.60–0.92]) and specific components of primary outcome (myocardial infarction, RR 0.85 [0.73–0.98]; stroke, RR 0.79 [0.65–0.95]), with no significant effect on cardiac death and revascularization.

Conclusion

These results support the efficacy of low‐dose colchicine in reducing MACEs when added to standard care for at least 12 months.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColchicineCardiovascular DiseasesHumansRandomized Controlled Trials as TopicSecondary PreventionMyocardial Infarction

Stichwörter der Autor:innen

cardiovascular preventioncolchicineinflammationmajor adverse cardiovascular eventsmeta‐analysis

Substanzen

Colchicine

Autor:innen und Institutionen

  • Epidemiology and Preventive Pharmacology Service (SEFAP), Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.
  • IRCCS MultiMedica, Sesto San Giovanni (MI), Italy.

Zitieren

APA

Xie, S., Galimberti, F., Olmastroni, E., Catapano, A. L., & Casula, M. (2025). Colchicine and cardiovascular events: An updated meta‐analysis of published randomized controlled trials. Journal of Internal Medicine, 298(6), 711-717. https://doi.org/10.1111/joim.20107

Vancouver

Xie S, Galimberti F, Olmastroni E, Catapano AL, Casula M. Colchicine and cardiovascular events: An updated meta‐analysis of published randomized controlled trials. Journal of Internal Medicine. 2025;298(6):711-717. doi:10.1111/joim.20107

BibTeX
@article{Xie2025,
  author = {Xie, Sining and Galimberti, Federica and Olmastroni, Elena and Catapano, Alberico L and Casula, Manuela},
  title = {Colchicine and cardiovascular events: An updated meta‐analysis of published randomized controlled trials},
  journal = {Journal of Internal Medicine},
  year = {2025},
  volume = {298},
  number = {6},
  pages = {711--717},
  doi = {10.1111/joim.20107}
}
Kostenlos starten →